PT975761E - Interferao beta humano recombinante com solubilidade melhorada - Google Patents

Interferao beta humano recombinante com solubilidade melhorada

Info

Publication number
PT975761E
PT975761E PT98920533T PT98920533T PT975761E PT 975761 E PT975761 E PT 975761E PT 98920533 T PT98920533 T PT 98920533T PT 98920533 T PT98920533 T PT 98920533T PT 975761 E PT975761 E PT 975761E
Authority
PT
Portugal
Prior art keywords
phe
leu
recombinant human
human beta
improved solubility
Prior art date
Application number
PT98920533T
Other languages
English (en)
Inventor
Gero Waschutza
Bernd Otto
Christian Schneider-Fresenius
Original Assignee
Fraunhofer Ges Zur For Der Ang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fraunhofer Ges Zur For Der Ang filed Critical Fraunhofer Ges Zur For Der Ang
Publication of PT975761E publication Critical patent/PT975761E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/215—IFN-beta
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/565—IFN-beta

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
PT98920533T 1997-04-23 1998-04-16 Interferao beta humano recombinante com solubilidade melhorada PT975761E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19717864A DE19717864C2 (de) 1997-04-23 1997-04-23 Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung

Publications (1)

Publication Number Publication Date
PT975761E true PT975761E (pt) 2004-05-31

Family

ID=7827959

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98920533T PT975761E (pt) 1997-04-23 1998-04-16 Interferao beta humano recombinante com solubilidade melhorada

Country Status (10)

Country Link
US (3) US6572853B1 (pt)
EP (1) EP0975761B1 (pt)
JP (1) JP4189035B2 (pt)
AT (1) ATE257859T1 (pt)
CA (1) CA2287521C (pt)
DE (2) DE19717864C2 (pt)
DK (1) DK0975761T3 (pt)
ES (1) ES2214709T3 (pt)
PT (1) PT975761E (pt)
WO (1) WO1998048018A1 (pt)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung
US20080076706A1 (en) 1997-07-14 2008-03-27 Bolder Biotechnology, Inc. Derivatives of Growth Hormone and Related Proteins, and Methods of Use Thereof
US6753165B1 (en) 1999-01-14 2004-06-22 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
CN1269805A (zh) 1997-07-14 2000-10-11 博尔德生物技术公司 生长激素和相关蛋白的衍生物
US8288126B2 (en) 1999-01-14 2012-10-16 Bolder Biotechnology, Inc. Methods for making proteins containing free cysteine residues
US6514729B1 (en) * 1999-05-12 2003-02-04 Xencor, Inc. Recombinant interferon-beta muteins
US7144574B2 (en) 1999-08-27 2006-12-05 Maxygen Aps Interferon β variants and conjugates
US7431921B2 (en) 2000-04-14 2008-10-07 Maxygen Aps Interferon beta-like molecules
US6531122B1 (en) 1999-08-27 2003-03-11 Maxygen Aps Interferon-β variants and conjugates
IL156059A0 (en) * 2001-02-27 2003-12-23 Maxygen Aps NEW INTERFERON beta-LIKE MOLECULES
WO2004020468A2 (en) * 2002-08-28 2004-03-11 Maxygen Aps Interferon beta-like molecules for treatment of cancer
CA2498319A1 (en) 2002-09-09 2004-03-18 Nautilus Biotech Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules
EP1581631A4 (en) * 2002-10-01 2007-09-05 Xencor Inc INTERFERON VARIANTS HAVING IMPROVED PROPERTIES
EP1636256A2 (en) * 2003-06-10 2006-03-22 Xencor, Inc. Interferon variants with improved properties
JP4896745B2 (ja) 2004-02-02 2012-03-14 アンブレツクス・インコーポレイテツド 修飾されたヒトインターフェロンポリペプチドおよびこれらの使用
KR100781666B1 (ko) 2004-11-02 2007-12-03 신영기 인간 인터페론-베타 변이체
WO2007110231A2 (en) * 2006-03-28 2007-10-04 Nautilus Biotech, S.A. MODIFIED INTERFERON-β (IFN-β) POLYPEPTIDES
AU2007248680C1 (en) * 2006-05-02 2014-01-23 Allozyne, Inc. Non-natural amino acid substituted polypeptides
WO2008137471A2 (en) 2007-05-02 2008-11-13 Ambrx, Inc. Modified interferon beta polypeptides and their uses
CA2712606A1 (en) 2008-02-08 2009-08-13 Ambrx, Inc. Modified leptin polypeptides and their uses
DE102008051574A1 (de) 2008-10-14 2010-04-15 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Verfahren zur Herstellung von Interferon-beta und deren Varianten
EP2431051A1 (en) * 2010-09-15 2012-03-21 Vakzine Projekt Management GmbH Type-1 interferons for the treatment of multiple sclerosis
CN109134642A (zh) 2011-10-01 2019-01-04 株式会社糖锁工学研究所 加成糖链的多肽及含有该多肽的医药组合物
ES2687801T3 (es) 2013-03-29 2018-10-29 Glytech, Inc. Polipéptido presentando cadenas de azúcares sialiladas unidas al mismo

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4588585A (en) * 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
GB8412564D0 (en) 1984-05-17 1984-06-20 Searle & Co Structure and properties
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
DE19717864C2 (de) * 1997-04-23 2001-05-17 Fraunhofer Ges Forschung Humanes rekombinantes Interferon-beta, Verfahren zu seiner Herstellung und seine Verwendung

Also Published As

Publication number Publication date
ES2214709T3 (es) 2004-09-16
CA2287521A1 (en) 1998-10-29
DK0975761T3 (da) 2004-02-16
JP2001523957A (ja) 2001-11-27
US7052687B2 (en) 2006-05-30
CA2287521C (en) 2009-08-11
US6572853B1 (en) 2003-06-03
US20060093579A1 (en) 2006-05-04
WO1998048018A1 (de) 1998-10-29
EP0975761B1 (de) 2004-01-14
DE59810596D1 (de) 2004-02-19
US7575894B2 (en) 2009-08-18
JP4189035B2 (ja) 2008-12-03
DE19717864A1 (de) 1998-10-29
US20040022763A1 (en) 2004-02-05
DE19717864C2 (de) 2001-05-17
ATE257859T1 (de) 2004-01-15
EP0975761A1 (de) 2000-02-02

Similar Documents

Publication Publication Date Title
PT975761E (pt) Interferao beta humano recombinante com solubilidade melhorada
DE69435049D1 (de) Chimäre proteine zur vermeidung der komplementaktivierung
EP0307592A3 (de) Varianten des pankreatischen Rinder-Trypsininhibitors, deren Herstellung und Verwendung
BG103335A (en) Application of fumaric acid derivatives
HU9200548D0 (en) Improved activity process of recombined proteins
GR3006172T3 (pt)
GB8700204D0 (en) Pancreatic secretory trypsin inhibitor & variants
FI20075338A (fi) gb350/220:n ei silmukoivia muutoksia
WO2002101052A3 (en) Salutaridinol 7-o-acetyltransferase and derivatives thereof
MX167236B (es) Peptidos sinteticos de timosina -1 y metodo para su obtencion
AU579593B2 (en) Novel peptides which are active on the central nervous system and have an action on the cholinergic system
AUPN154295A0 (en) Nucleic acid molecule encoding a protein with avian gamma-interferon activity
ES8900018A1 (es) Procedimiento para la fabricacion de derivados aminoalcoholes peptidicos inhibidores de la renina y de las proteasas acidas
IT8647912A0 (it) Procedimento enzimatico per preparare l'amminoacidi contenenti zolfo
DE59606266D1 (de) Verbesserung der Verträglichkeit von pharmazeutisch wirksamen Beta-Aminosäuren
DE69102069D1 (de) 5-aminosalicylsäurederivate zur therapie chronisch entzündlicher baucherkrankungen.
DE59410423D1 (de) Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose
ATE224403T1 (de) Verwendung von kaseinfragmenten als wachstumerförderer
AU637589B2 (en) Ancrod proteins, their production and use
EP0296227A4 (en) ADMINISTRATION OF AMINOACIDS BY NASAL ROUTE.
AR243865A1 (es) Procedimientos para fabricar derivados de aminoacidos; y silil derivados de aminoacidos utiles como intermediarios en dicho procedimiento.
ATE283914T1 (de) Iga1-protease fragment als trägerpeptid
AU1454495A (en) Recombinant production of modified proteins lacking certain amino acids
ATE130872T1 (de) Ancrod ähnliche proteine, ihre herstellung und verwendung.
EP1295943A4 (en) POLYPEPTIDES CAPABLE THE POWER TO STIMULATE NEUTROPHILES